Latest News for: braf

Edit

Understanding the BRAF and mTOR Pathway

Rumble 09 Dec 2025
Click the Rumble article link to see the video ....
Edit

New drug combo nearly doubles survival for BRAF-mutated lung cancer patients, trial shows

The Jerusalem Post 27 Nov 2025
First-line use of encorafenib and binimetinib in BRAF V600E NSCLC recorded a median overall survival of 47.6 months, according to data presented at the ESMO congress ....
Edit

Ono Receives Supplemental Approval of Combination Therapy with BRAFTOVI® Capsule, a BRAF Inhibitor, for the Indication of Colorectal Cancer (ONO Pharmaceutical Co Ltd)

Public Technologies 20 Nov 2025
encorafenib) Capsule (“Braftovi”), a BRAF inhibitor, in combination with cetuximab, an anti-human EGFR monoclonal antibody, and chemotherapy for the indication of unresectable, advanced or recurrent colorectal cancer (CRC) with BRAF mutation.
Edit

SITC 2025 Poster Presentation: Dual targeting of TGF-b and EGFR with ficerafusp alfa shows superior antitumor activity over cetuximab in KRAS/BRAF wild-type MSS colorectal cancer cell lines (Bicara Therapeutics Inc)

Public Technologies 08 Nov 2025
) Dual targeting of TGF-β and EGFR with ficerafusp alfa shows superior antitumor activity over cetuximab in KRAS/BRAF wild-type MSS colorectal cancer cell lines ... BRAF-V600.
Edit

RP1 + Nivolumab in Patients with and without prior BRAF-Directed Therapy at SITC 2025 (Replimune Group Inc)

Public Technologies 07 Nov 2025
Overall, 86.5% (77/89) and 94.1% (48/51) of patients with BRAF-WT and BRAF-mut melanoma, respectively, experienced at least 1 treatment-related adverse event (TRAE) of any grade (Table 3).
Edit

BRAF inhibition increases TGFβ2 production and stimulates metastasis in mice with endogenous BRAFV600E-induced hepatocellular carcinoma

PNAS 06 Nov 2025
.
Edit

BREC rejects agreement with BRAF-affiliated group and funds master plan alone

The Advocate 11 Oct 2025
During a meeting filled with confusion, the agency in charge of East Baton Rouge parks rejected giving a civic group foundation control over creating a master plan for the University Lakes area, deciding instead to pay more than $600,000 to ... .
Edit

BRAF Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast 2015-2036

Nasdaq Globe Newswire 22 Sep 2025
The BRAF Tests market presents significant opportunities in melanoma treatment, driven by technological advancements and regulatory insights.
Edit

BRAF Mutated Non-small Cell Lung Cancer Market Dynamics Indicate Upward Trajectory Through 2034, Reports DelveInsight ...

GetNews 18 Sep 2025
To Know in detail about the BRAF Mutated Non-small Cell Lung Cancer market outlook, drug uptake, treatment scenario and epidemiology trends, Click here;. Some of the key facts of the BRAF Mutated Non-small Cell Lung Cancer Market Report..
  • 1

Article Search

tools
×
×
×
×